HeLa cell

Also found in: Thesaurus, Medical, Legal, Financial, Encyclopedia, Wikipedia.

He·La cell

Any of the cells of the first continuously cultured human carcinoma strain, originally obtained from cancerous cervical tissue and maintained for use in biomedical research.

[From the first two letters of the first and last name of Henrietta Lacks (1920-1951), the American cancer patient from whom the cells were taken in 1951.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


(or He′la or he′la) cell`

(ˈhɛl ə)

a vigorous strain of laboratory-cultured cells descended from a human cervical cancer, used widely in research.
[after He(nrietta)La(cks), a patient from whom the cancer tissue was taken in 1951]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
References in periodicals archive ?
For the establishment of tumors, 200 [micro]l of HeLa cell suspension (suspended in saline) was administered subcutaneously at a concentration of 1 x [10.sup.7]/ml into the backs of 6-week-old female Balb/c nude mice.
The cells were the source of the HeLa cell line (derived from Lacks' name), the first immortalised cell line and an invaluable source of research.
The cells were the source of the HeLa cell line (derived from Lacks's name) - an invaluable source of research.
The cells were the source of the HeLa cell line (derived from Lacks' name) - an invaluable source of research.
This discovery of the HeLa cell, named after her, has led to advances in medical science for over 50 years.
B: There was a significant decrease in HeLa cell number percentage, P > 0.01 after treatment with 100 [micro]g/mL of strain 1, 2, 3, 4, 5, 7, and 8.
Although apigenin represents a promising chemotherapeutic agent for cancer therapy, little information is available regarding the effects of apigenin against cervical cancer, and the available data were mostly obtained in the HeLa cell line [39-42].
Human nasopharyngeal carcinoma CNE-2Z, human hepatoma Bel7404, and human cervical cancer HeLa cell lines obtained from Shanghai Biological Institute were cultured in RPMI-1640 (Invitrogen, America) containing 10% FBS (Hyclone, America) in 5% C[O.sub.2] at 37[degrees] C.
In contrast, in the SiHa and HeLa cell lines proteomics analysis, there was no difference when compared to HCK1T (0.8 and 0.7-fold change, resp.).
A novel L1 retrotransposon marker for HeLa cell line identification, BioTechniques 46(4): 277-84.
The amount of the externalization of phosphatidylserine (PS) from HeLa cell surfaces was determined by the Annexin-V-FITC staining kit (Abeam, Germany) according to the manufacturer's instructions.